Xiaofeng Zhao

机构：Gilead Sciences (United States)

发表论文 30 篇 · 总被引 429 次 · h-index 13

代表论文

• Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C -Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV (2021 · Journal of Medicinal Chemistry · 被引 90)
• Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells (2021 · Antimicrobial Agents and Chemotherapy · 被引 63)
• Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection (2021 · Science Translational Medicine · 被引 42)
• Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 Inhibition (2021 · Drug Metabolism and Disposition · 被引 27)
• In Vitro Hepatic Uptake in Human and Monkey Hepatocytes in the Presence and Absence of Serum Protein and Its In Vitro to In Vivo Extrapolation (2020 · Drug Metabolism and Disposition · 被引 24)
• Mid‐ and Long‐Term Follow‐Up Efficacy Analysis of 3D ‐Printed Interbody Fusion Cages for Anterior Cervical Discectomy and Fusion (2021 · Orthopaedic Surgery · 被引 19)